JK
Jayaraman Kannappan
About Jayaraman Kannappan
Data last updated:
Jayaraman Kannappan is a Whole-Time Director at Apicore Pharmaceuticals Private Limited (since 2014). The company operates in Pharma. Apicore Pharmaceuticals Private Limited reported revenue of ₹195 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Apicore Pharmaceuticals Private Limited U24119GJ2006FTC048777 | Whole-Time Director | 19 Nov 2014 | 2006 | ₹195 Cr (FY 2024) | Active |
Board colleagues of Jayaraman Kannappan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anjali Hemant Prasad | Apicore Pharmaceuticals Private Limited | Company Secretary | |
| Mahesh Suresh Javale | 10390685 | Apicore Pharmaceuticals Private Limited | Nominee Director |
| Murali Krishna Madala | 00928526 | Apicore Pharmaceuticals Private Limited | Managing Director |
| Parthiv Patel | 07876985 | Apicore Pharmaceuticals Private Limited | Director |
| Ravishanker Kovi | 00278107 | Apicore Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jayaraman Kannappan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jayaraman Kannappan
Jayaraman Kannappan currently holds 1 directorship: Apicore Pharmaceuticals Private Limited (Whole-Time Director, since 19 Nov 2014, revenue ₹195 Cr (FY 2024)).
Jayaraman Kannappan was first appointed on 19 Nov 2014 as Whole-Time Director at Apicore Pharmaceuticals Private Limited.
The current boards of Jayaraman Kannappan's companies include Anjali Hemant Prasad (Apicore Pharmaceuticals Private Limited), Mahesh Suresh Javale (Apicore Pharmaceuticals Private Limited), Murali Krishna Madala (Apicore Pharmaceuticals Private Limited), Parthiv Patel (Apicore Pharmaceuticals Private Limited), Ravishanker Kovi (Apicore Pharmaceuticals Private Limited).